IBDEI072 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2793,1,4,0)
 ;;=4^T84.52XA
 ;;^UTILITY(U,$J,358.3,2793,2)
 ;;=^5055388
 ;;^UTILITY(U,$J,358.3,2794,0)
 ;;=T84.51XA^^7^83^178
 ;;^UTILITY(U,$J,358.3,2794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2794,1,3,0)
 ;;=3^Prosthetic Right Hip Joint Infection,Init Encntr
 ;;^UTILITY(U,$J,358.3,2794,1,4,0)
 ;;=4^T84.51XA
 ;;^UTILITY(U,$J,358.3,2794,2)
 ;;=^5055385
 ;;^UTILITY(U,$J,358.3,2795,0)
 ;;=T84.54XA^^7^83^177
 ;;^UTILITY(U,$J,358.3,2795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2795,1,3,0)
 ;;=3^Prosthetic Left Knee Joint Infection,Init Encntr
 ;;^UTILITY(U,$J,358.3,2795,1,4,0)
 ;;=4^T84.54XA
 ;;^UTILITY(U,$J,358.3,2795,2)
 ;;=^5055394
 ;;^UTILITY(U,$J,358.3,2796,0)
 ;;=T84.53XA^^7^83^179
 ;;^UTILITY(U,$J,358.3,2796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2796,1,3,0)
 ;;=3^Prosthetic Right Knee Joint Infection,Init Encntr
 ;;^UTILITY(U,$J,358.3,2796,1,4,0)
 ;;=4^T84.53XA
 ;;^UTILITY(U,$J,358.3,2796,2)
 ;;=^5055391
 ;;^UTILITY(U,$J,358.3,2797,0)
 ;;=T84.59XA^^7^83^180
 ;;^UTILITY(U,$J,358.3,2797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2797,1,3,0)
 ;;=3^Prosthetic Shoulder Joint Infection,Init Encntr
 ;;^UTILITY(U,$J,358.3,2797,1,4,0)
 ;;=4^T84.59XA
 ;;^UTILITY(U,$J,358.3,2797,2)
 ;;=^5055397
 ;;^UTILITY(U,$J,358.3,2798,0)
 ;;=T82.6XXA^^7^83^175
 ;;^UTILITY(U,$J,358.3,2798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2798,1,3,0)
 ;;=3^Prosthetic Heart Valve Infection, initial encounter
 ;;^UTILITY(U,$J,358.3,2798,1,4,0)
 ;;=4^T82.6XXA
 ;;^UTILITY(U,$J,358.3,2798,2)
 ;;=^5054908
 ;;^UTILITY(U,$J,358.3,2799,0)
 ;;=N12.^^7^83^183
 ;;^UTILITY(U,$J,358.3,2799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2799,1,3,0)
 ;;=3^Pyelonephritis
 ;;^UTILITY(U,$J,358.3,2799,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,2799,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,2800,0)
 ;;=J30.9^^7^83^184
 ;;^UTILITY(U,$J,358.3,2800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2800,1,3,0)
 ;;=3^Rhinitis, allergic
 ;;^UTILITY(U,$J,358.3,2800,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,2800,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,2801,0)
 ;;=B86.^^7^83^186
 ;;^UTILITY(U,$J,358.3,2801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2801,1,3,0)
 ;;=3^Scabies
 ;;^UTILITY(U,$J,358.3,2801,1,4,0)
 ;;=4^B86.
 ;;^UTILITY(U,$J,358.3,2801,2)
 ;;=^108096
 ;;^UTILITY(U,$J,358.3,2802,0)
 ;;=M00.9^^7^83^189
 ;;^UTILITY(U,$J,358.3,2802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2802,1,3,0)
 ;;=3^Septic Joint/Arthritis
 ;;^UTILITY(U,$J,358.3,2802,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,2802,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,2803,0)
 ;;=B02.9^^7^83^193
 ;;^UTILITY(U,$J,358.3,2803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2803,1,3,0)
 ;;=3^Shingles/zoster
 ;;^UTILITY(U,$J,358.3,2803,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,2803,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,2804,0)
 ;;=J01.90^^7^83^194
 ;;^UTILITY(U,$J,358.3,2804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2804,1,3,0)
 ;;=3^Sinusitis, acute
 ;;^UTILITY(U,$J,358.3,2804,1,4,0)
 ;;=4^J01.90
 ;;^UTILITY(U,$J,358.3,2804,2)
 ;;=^5008127
 ;;^UTILITY(U,$J,358.3,2805,0)
 ;;=J32.9^^7^83^195
 ;;^UTILITY(U,$J,358.3,2805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2805,1,3,0)
 ;;=3^Sinusitis, chronic
 ;;^UTILITY(U,$J,358.3,2805,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,2805,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,2806,0)
 ;;=A49.01^^7^83^143
 ;;^UTILITY(U,$J,358.3,2806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2806,1,3,0)
 ;;=3^Methicillin Susceptible Staphylococcus Aureus Infection
 ;;^UTILITY(U,$J,358.3,2806,1,4,0)
 ;;=4^A49.01
 ;;^UTILITY(U,$J,358.3,2806,2)
 ;;=^5000235
 ;;
 ;;$END ROU IBDEI072
